Balance Sheet Account Details - Narrative (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended |
|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2021 |
Dec. 31, 2020 |
|
| Product Information [Line Items] | |||
| Accounts receivable | $ 2,838,000 | $ 2,838,000 | $ 2,775,000 |
| Recovery of bad debt expense | (15,000) | (40,000) | |
| Lineagen | |||
| Product Information [Line Items] | |||
| Accounts receivable | $ 606,000 | $ 606,000 | |
| One Customer | Accounts Receivable | Customer Concentration Risk | |||
| Product Information [Line Items] | |||
| Concentration risk percentage | 10.10% | ||
| Two Customers | Accounts Receivable | Customer Concentration Risk | |||
| Product Information [Line Items] | |||
| Concentration risk percentage | 27.40% |
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in allowance for credit loss on accounts receivable, from recovery. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|